Evidence map›Paper›PMID 42011295›Full record

ArticleComprehensive psychoneuroendocrinology2026

Plasma metabolomics and red blood cell fatty acid profiles in adolescent mental health.

Aino-Kaisa Piironen, Alexey M Afonin, Iman Zarei, Ville Koistinen, Marko Lehtonen, Venla Hämäläinen, Aleix Sala-Vila, Iolanda Lázaro, Jordi Julvez, Irene van Kamp and 1 more

Abstract read
In one paragraph

Article in Comprehensive psychoneuroendocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aino-Kaisa PiironenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, FI-70211, Kuopio, Finland.
Alexey M AfoninA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, FI-70211, Kuopio, Finland.
Iman ZareiInstitute of Public Health and Clinical Nutrition, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 3, FI-70211, Kuopio, Finland.
Ville KoistinenInstitute of Public Health and Clinical Nutrition, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 3, FI-70211, Kuopio, Finland.
Marko LehtonenSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 3, FI-70211, Kuopio, Finland.
Venla HämäläinenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, FI-70211, Kuopio, Finland.
Aleix Sala-VilaCardiovascular Risk and Nutrition, Hospital del Mar Medical Research Institute, Dr. Aiguader 88, 08003, Barcelona, Spain.
Iolanda LázaroCardiovascular Risk and Nutrition, Hospital del Mar Medical Research Institute, Dr. Aiguader 88, 08003, Barcelona, Spain.
Jordi JulvezClinical and Epidemiological Neuroscience (NeuroÈpia), Institut d'Investigació Sanitària Pere Virgili (IISPV), Avinguda del Doctor Josep Laporte, 2, 43204, Reus, Spain.
Irene van KampCentre for Sustainability, Environment and Health, National Institute for Public Health and the Environment, Antonie van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Katja M KanninenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, FI-70211, Kuopio, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rising mental health challenges among adolescents are a global priority, yet tools to identify at-risk individuals remain limited. The development of objective tools, such as plasma biomarkers, could enhance the implementation of early preventive strategies for individuals at increased risk. We explored plasma metabolites associated with overall psychosocial difficulties in 197 adolescents aged 11-16 from the WALNUTS study. Psychosocial difficulties were assessed using self-reported Strengths and Difficulties Questionnaire (SDQ) scores. Plasma metabolomics data were generated by untargeted liquid chromatography high-resolution mass spectrometry using cross-sectional plasma samples. Linear regression modelling was performed to identify associations between plasma metabolites and the total SDQ score. Logistic regression and Precision-Recall curves were used to evaluate the classification performance of candidate metabolites in distinguishing the SDQ groups (low: 0-14; raised: 15-25). Additionally, pre-existing red blood cell fatty acid profile data were analysed to detect differences between the low and the raised SDQ score groups. Three metabolites: isoleucine, pregnenolone sulfate, and lysophosphatidylcholine 20:1, were significantly associated with the SDQ score, and are involved in energy metabolism, neuronal functions and phospholipid-related signalling. In addition, a trend towards lower proportions of red blood cell

Indexed as

AdolescentsBiomarkerGlobal metabolomicsLiquid chromatography-mass spectrometryPsychopathology

Identifiers

PMID42011295
PMCPMC13092191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.